Literature DB >> 15466386

Impaired lung dendritic cell activation in CCR2 knockout mice.

Bo-Chin Chiu1, Christine M Freeman, Valerie R Stolberg, Jerry S Hu, Kyriaki Zeibecoglou, Bao Lu, Craig Gerard, Israel F Charo, Sergio A Lira, Stephen W Chensue.   

Abstract

Dendritic cell (DC) recruitment is a hallmark event in antigen (Ag)-challenged lungs. We previously reported models for analyzing DC migration and activation in the lung after Th1- or Th2-eliciting pathogen Ag-bead challenge. To determine the role of chemokines in DC mobilization, we applied this analysis to CCR1, CCR2, CCR5, and CCR6 chemokine receptor knockout mice. Both Mycobacteria bovis protein Ags and helminthic, Schistosoma mansoni egg Ags elicited multiple chemokines, including CCR1, CCR2, CCR5, and to a lesser extent CCR6 ligands. DCs from wild-type lungs expressed transcripts for chemokine receptors, CCR1, CCR2, CCR5, and CXCR4. In all knockout strains, CD11c+ cells were recruited to Ag-beads likely because of receptor redundancy. However, DCs in CCR2-/- mice had significantly decreased MHCII and CD40 expression. This was associated with abrogated cytokine production in draining lymph node cultures. Analysis of local innate inflammation revealed a 50% reduction in macrophage recruitment in CCR2-/- mice. Bone marrow chimeras of mixed CCR2+/+ green fluorescent protein transgenic and CCR2-/- green fluorescent protein-negative cells confirmed the DC maturation defect was only among the latter population. In conclusion, CCR2 knockout confers an intrinsic DC activation defect and CCR2 ligands likely promote the local activation/maturation of inflammatory DCs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15466386      PMCID: PMC1599791          DOI: 10.1016/S0002-9440(10)63380-9

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  46 in total

Review 1.  The role of chemokine receptors in primary, effector, and memory immune responses.

Authors:  F Sallusto; C R Mackay; A Lanzavecchia
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue.

Authors:  D N Cook; D M Prosser; R Forster; J Zhang; N A Kuklin; S J Abbondanzo; X D Niu; S C Chen; D J Manfra; M T Wiekowski; L M Sullivan; S R Smith; H B Greenberg; S K Narula; M Lipp; S A Lira
Journal:  Immunity       Date:  2000-05       Impact factor: 31.745

3.  Cutting edge: immature dendritic cells generated from monocytes in the presence of TGF-beta 1 express functional C-C chemokine receptor 6.

Authors:  D Yang; O M Howard; Q Chen; J J Oppenheim
Journal:  J Immunol       Date:  1999-08-15       Impact factor: 5.422

4.  Defects in the generation of IFN-gamma are overcome to control infection with Leishmania donovani in CC chemokine receptor (CCR) 5-, macrophage inflammatory protein-1 alpha-, or CCR2-deficient mice.

Authors:  N Sato; W A Kuziel; P C Melby; R L Reddick; V Kostecki; W Zhao; N Maeda; S K Ahuja; S S Ahuja
Journal:  J Immunol       Date:  1999-11-15       Impact factor: 5.422

5.  Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus.

Authors:  T C Dawson; M A Beck; W A Kuziel; F Henderson; N Maeda
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

6.  Enhanced pulmonary allergic responses to Aspergillus in CCR2-/- mice.

Authors:  K Blease; B Mehrad; T J Standiford; N W Lukacs; J Gosling; L Boring; I F Charo; S L Kunkel; C M Hogaboam
Journal:  J Immunol       Date:  2000-09-01       Impact factor: 5.422

7.  Localization of distinct Peyer's patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP)-3alpha, MIP-3beta, and secondary lymphoid organ chemokine.

Authors:  A Iwasaki; B L Kelsall
Journal:  J Exp Med       Date:  2000-04-17       Impact factor: 14.307

8.  CC chemokine receptor (CCR)2 is required for langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines, b cell outgrowth, and sustained neutrophilic inflammation.

Authors:  N Sato; S K Ahuja; M Quinones; V Kostecki; R L Reddick; P C Melby; W A Kuziel; S S Ahuja
Journal:  J Exp Med       Date:  2000-07-17       Impact factor: 14.307

9.  CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis.

Authors:  B T Fife; G B Huffnagle; W A Kuziel; W J Karpus
Journal:  J Exp Med       Date:  2000-09-18       Impact factor: 14.307

10.  Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors.

Authors:  M C Dieu-Nosjean; C Massacrier; B Homey; B Vanbervliet; J J Pin; A Vicari; S Lebecque; C Dezutter-Dambuyant; D Schmitt; A Zlotnik; C Caux
Journal:  J Exp Med       Date:  2000-09-04       Impact factor: 14.307

View more
  22 in total

1.  Severe sepsis exacerbates cell-mediated immunity in the lung due to an altered dendritic cell cytokine profile.

Authors:  Haitao Wen; Cory M Hogaboam; Jack Gauldie; Steven L Kunkel
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

Review 2.  Respiratory dendritic cells: mediators of tolerance and immunity.

Authors:  Ryan A Langlois; Kevin L Legge
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

Review 3.  The role of chemokines in virus-associated asthma exacerbations.

Authors:  Lara E Kallal; Nicholas W Lukacs
Journal:  Curr Allergy Asthma Rep       Date:  2008-09       Impact factor: 4.806

4.  Heterogeneity of lung mononuclear phagocytes during pneumonia: contribution of chemokine receptors.

Authors:  Lanlin Chen; Zhimin Zhang; Kathryn E Barletta; Marie D Burdick; Borna Mehrad
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-09-20       Impact factor: 5.464

5.  Cysteine-cysteinyl chemokine receptor 6 mediates invariant natural killer T cell airway recruitment and innate stage resistance during mycobacterial infection.

Authors:  Valerie R Stolberg; Bo-chin Chiu; Brian E Martin; Samir A Shah; Matyas Sandor; Stephen W Chensue
Journal:  J Innate Immun       Date:  2010-10-29       Impact factor: 7.349

6.  CC chemokine receptor 4 contributes to innate NK and chronic stage T helper cell recall responses during Mycobacterium bovis infection.

Authors:  Valerie R Stolberg; Bo-Chin Chiu; Brian M Schmidt; Steven L Kunkel; Matyas Sandor; Stephen W Chensue
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

7.  Early induction of CCL7 downstream of TLR9 signaling promotes the development of robust immunity to cryptococcal infection.

Authors:  Yafeng Qiu; Stuart Zeltzer; Yanmei Zhang; Fuyuan Wang; Gwo-Hsiao Chen; Jeremy Dayrit; Benjamin J Murdock; Urvashi Bhan; Galen B Toews; John J Osterholzer; Theodore J Standiford; Michal A Olszewski
Journal:  J Immunol       Date:  2012-03-14       Impact factor: 5.422

8.  In vivo mechanisms involved in enhanced protection utilizing an Fc receptor-targeted mucosal vaccine platform in a bacterial vaccine and challenge model.

Authors:  Constantine Bitsaktsis; Zulfia Babadjanova; Edmund J Gosselin
Journal:  Infect Immun       Date:  2014-10-13       Impact factor: 3.441

9.  CCR2 and CCR6, but not endothelial selectins, mediate the accumulation of immature dendritic cells within the lungs of mice in response to particulate antigen.

Authors:  John J Osterholzer; Theresa Ames; Timothy Polak; Joanne Sonstein; Bethany B Moore; Stephen W Chensue; Galen B Toews; Jeffrey L Curtis
Journal:  J Immunol       Date:  2005-07-15       Impact factor: 5.422

10.  CCR2 regulates monocyte recruitment as well as CD4 T1 allorecognition after lung transplantation.

Authors:  A E Gelman; M Okazaki; S Sugimoto; W Li; C G Kornfeld; J Lai; S B Richardson; F H Kreisel; H J Huang; J R Tietjens; B H Zinselmeyer; G A Patterson; M J Miller; A S Krupnick; D Kreisel
Journal:  Am J Transplant       Date:  2010-05       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.